9JD-94323-71687
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 488 / MI
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- VFM-11171-75720
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-28
Dose 1 — Moderna
-
2022-06-30
Registered in v-safe
- 2022-06-30
- 2022-07-03
- 2022-07-06
- 2022-07-12
- 2022-07-21
-
2022-07-26
Dose 2 — Moderna
-
2022-07-30
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-07-31
-
2022-08-01
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-08-04
- 2022-08-23
-
2022-09-01
Survey response — day 35, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Cough, running noseMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-28 | Moderna | No |
| 2 | 2022-07-26 | Moderna | No |
Free text
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Cough, running nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release